頁籤選單縮合
題名 | Delirium Associated with Bupropion Sustained Release=與威博雋持續藥效錠(Bupropion Sustained Release)有關的譫妄 |
---|---|
作者 | 王姿云; 黃三原; 夏一新; 毛衛中; 陳興剛; Wang, Tzu-yun; Huang, San-yuan; Shiah, I-shin; Mao, Wei-chung; Chen, Chih-kang; |
期刊 | Journal of Medical Sciences |
出版日期 | 20090800 |
卷期 | 29:4 2009.08[民98.08] |
頁次 | 頁209-211 |
分類號 | 415.981 |
語文 | eng |
關鍵詞 | 譫妄; Bupropion; Delirium; Bipolar disorder; |
英文摘要 | Bupropion is a newer antidepressant with the main pharmacological effects of dopamine and norepinephrine reuptake inhibition. The usage of bupropion is relatively safe with minor side effects. In some rare instances, psychosis and delirium may emerge because of its potentiating effects on dopaminergic neurotransmission. Here we presented a case of bupropion SR (300mg/day) related to delirium with concurrent quetiapine (400mg/day) usage. Although there are fewer side effect profiles of bupropion SR, our case revealed acute delirium after administration of a therapeutic dosage of bupropion. Poor cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2B6 (CYP2B6) metabolism and underlying bipolarity may contribute to this adverse effect. Clinicians should be cautioned when prescribing bupropion SR to vulnerable populations. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。